Litcius/Paper detail

SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells

Quirin Hammer, Josefine Dunst, Wanda Christ, Francesca Picarazzi, Mareike Wendorff, Pouria Momayyezi, Oisín Huhn, Herman Netskar, Kimia T. Maleki, Marina García, Takuya Sekine, Ebba Sohlberg, Valerio Azzimato, Myriam Aouadi, Frauke Degenhardt, André Franke, Francesco Spallotta, Mattia Mori, Jakob Michaëlsson, Niklas K. Björkström, Timo Rückert, Chiara Romagnani, Amir Horowitz, Jonas Klingström, Hans‐Gustaf Ljunggren, Karl‐Johan Malmberg

2022Cell Reports67 citationsDOIOpen Access PDF

Abstract

NK cells, resulting in missing self-recognition.

Topics & Concepts

Innate immune systemImmune systemBiologyImmunologyInterleukin 21Interleukin 12VirusIn vitroVirologyCytotoxic T cellT cellBiochemistryImmune Cell Function and InteractionCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research
SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells | Litcius